Objective: India with a broad drug clinical trial market, and Australia with a long history of drug clinical trial supervision, were chosen to compare the implementation status and supervision methods of clinical trials with China, so as to provide countermeasures for the scientific supervision of clinical trials in China. Method: Theoretical analysis methods such as literature research method, comparative analysis method were adopted.To analyze and discuss from the perspectives of domestic and foreign laws and regulations, test processes, and test objects, and the differences in clinical trial supervision between domestic and foreign countries were compared. Results: Clinical trial is a process of scientific evaluation of the effectiveness and safety of drugs, and it is an important link in the process of drug development. With the vigorous development of pharmaceutical industry in China, the number of clinical trials of drugs has increased significantly, but more and more problems exposed in the management of clinical trials should not be underestimated. Clinical trial supervision in our country is still inadequate, superior clinical trial resources are scarce, and the clinical trial management system is still incomplete. Conclusion: China should learn from foreign experience, formulate more perfect supervision and regulations, and improve the quality of drug clinical trials, to truly improve the level of supervision of drug clinical trials in China. |